Myasthenia gravis represents chronic autoimmune condition that primarily targets the neuromuscular junction. This junction enables the conveyance of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system incorrectly attacks these receptors, leading weakness and fatigue in the motor units. The indications